Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy
Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals.
Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans
Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide.
Democrats’ Midterm Wins Could Reshape Healthcare Access for Underserved Americans
Democrats' huge wins last week might mean big changes coming to healthcare across the country, especially in states which flipped blue. How might the shift in power affect affordability, access, and coverage?
presented by
Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality?
In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise Health, told MedCity News Editor-in-Chief Arundhati Parmar that the company's platform provides pricing data for medical services, medical devices, and pharmaceutical drugs.
Follow the Leader: How to Build and Retain Great Clinical Teams
We spend more than a decade training physicians and teach them almost nothing about leading people. So, what do we do? We take the best clinician in the group, hand them the title, and assume that leadership comes with it.